Neelakshi Bhagat is an Ophthalmology physician affiliated with Rutgers. OpenAlex indexes 276 publications with 4,256 citations (h-index 33); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
90 Bergen St
Doc - 6th Floor;
Newark, NJ 071032425
Telephone
973-972-2032Provider last certified this registry record 13 Apr 2022.
Clinical trials
- Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery
Sponsor: Bhagat, Neelakshi, M.D., M.P.H.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbVie Inc.Program year202310 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
88.3%Corticosteroid46.2%Prednisolone Acetate100%Part D≥21 patientsalpha-Adrenergic Agonist32.4%Brimonidine Tartrate100%Part D≥15 patients+ 1 more class in this area
Musculoskeletal
11.7%Cyclooxygenase Inhibitor11.7%Ketorolac Tromethamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events
International Ophthalmology
2023 - Epidemiologic trends in pediatric ocular injury in the USA from 2010 to 2019
Graefe s Archive for Clinical and Experimental Ophthalmology
2021 - Risk factors for central retinal vein occlusion in young adults
European Journal of Ophthalmology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Sherine Gabriel, MD
Rutgers
Julius Gardin, MD
Rutgers
Abraham Aviv, MD
Rutgers
Partho Sengupta, MD, DM
Rutgers
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”